Palantir stock slides into MLK break — what to watch before PLTR earnings
18 January 2026
1 min read

Palantir stock slides into MLK break — what to watch before PLTR earnings

New York, Jan 18, 2026, 06:13 EST — Market closed

  • Palantir shares ended Friday lower, underperforming a flat broader market into the long weekend.
  • Traders are bracing for potentially larger swings after January options contracts expired.
  • The next clear company catalyst is Palantir’s fourth-quarter results in early February.

Palantir Technologies Inc (PLTR) shares closed down 3.4% on Friday at $170.96, after swinging between $170.03 and $182.12, with about 59.5 million shares traded.

The drop came as U.S. stocks ended little changed in a choppy session and logged modest weekly losses, with Treasury yields rising after fresh uncertainty around the Federal Reserve’s next leadership and the start of earnings season. “One reason markets were ‘flat-lining’ was anticipation of more earnings releases,” Anthony Saglimbene, chief market strategist at Ameriprise Financial, said. 1

For traders, the timing matters. Friday’s monthly options expiration — when contracts that give investors the right to buy or sell shares at set prices run out — could open the door to bigger index moves in the days ahead, options specialists have warned. “I think this options expiration will allow the S&P 500 to start moving around a bit more,” said Brent Kochuba, founder of SpotGamma. 2

U.S. equity markets are closed on Monday for Martin Luther King Jr. Day and reopen on Tuesday. 3

That gap leaves a lot of room for headlines to hit at once — policy, rates, earnings — and Palantir sits in the part of the market that tends to feel it first. The company’s stock has been priced like a growth story, so a few basis points in yields or a shift in risk mood can show up fast.

Palantir said it will release fourth-quarter and full-year 2025 results on Monday, Feb. 2, after the close of U.S. markets, and will hold a webcast at 5:00 p.m. ET. 4

Investors will likely focus on whether demand in its commercial business keeps pace, how much work is coming from government customers, and whether margins hold up as the company pushes its Artificial Intelligence Platform into more customer deployments. Guidance matters more than the headline beat.

But there’s a catch. When a stock carries a rich valuation, small disappointments can turn into large moves — especially if rates keep edging higher or the broader market stops absorbing policy noise so easily.

The immediate read will come at Tuesday’s open: whether post-expiration volatility shows up in high-beta software names, and whether buyers step back in after Friday’s slide. The bigger marker is Feb. 2, when Palantir’s results and outlook land after the bell.

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Tesla stock heads into holiday week as regulators extend Full Self-Driving probe deadline
Previous Story

Tesla stock heads into holiday week as regulators extend Full Self-Driving probe deadline

IREN stock jumps 11% on AI tailwinds; traders brace for MLK Day break and next catalyst
Next Story

IREN stock jumps 11% on AI tailwinds; traders brace for MLK Day break and next catalyst

Go toTop